Appleton Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.57M | Sell |
34,054
-866
| -2% | -$186K | 0.53% | 58 |
|
|
2026
Q1 | $7.59M | Buy |
34,920
+743
| +2% | +$165K | 0.53% | 61 |
|
|
2025
Q4 | $7.81M | Sell |
34,177
-4,274
| -11% | -$974K | 0.51% | 64 |
|
|
2025
Q3 | $8.9M | Sell |
38,451
-1,291
| -3% | -$263K | 0.6% | 58 |
|
|
2025
Q2 | $7.38M | Buy |
39,742
+2,010
| +5% | +$374K | 0.52% | 65 |
|
|
2025
Q1 | $7.91M | Sell |
37,732
-2,189
| -5% | -$426K | 0.61% | 58 |
|
|
2024
Q4 | $7.09M | Sell |
39,921
-671
| -2% | -$123K | 0.52% | 64 |
|
|
2024
Q3 | $8.02M | Sell |
40,592
-1,201
| -3% | -$224K | 0.59% | 61 |
|
|
2024
Q2 | $7.17M | Sell |
41,793
-483
| -1% | -$80K | 0.55% | 62 |
|
|
2024
Q1 | $7.7M | Sell |
42,276
-1,569
| -4% | -$270K | 0.6% | 54 |
|
|
2023
Q4 | $6.79M | Sell |
43,845
-1,360
| -3% | -$198K | 0.55% | 59 |
|
|
2023
Q3 | $6.74M | Sell |
45,205
-1,011
| -2% | -$148K | 0.6% | 51 |
|
|
2023
Q2 | $6.23M | Buy |
46,216
+1,106
| +2% | +$162K | 0.53% | 56 |
|
|
2023
Q1 | $7.19M | Buy |
45,110
+497
| +1% | +$76K | 0.64% | 42 |
|
|
2022
Q4 | $7.21M | Sell |
44,613
-517
| -1% | -$79.3K | 0.68% | 38 |
|
|
2022
Q3 | $6.06M | Sell |
45,130
-274
| -0.6% | -$39.3K | 0.61% | 44 |
|
|
2022
Q2 | $6.95M | Sell |
45,404
-506
| -1% | -$77.3K | 0.66% | 43 |
|
|
2022
Q1 | $7.44M | Sell |
45,910
-106
| -0.2% | -$15.4K | 0.61% | 51 |
|
|
2021
Q4 | $6.23M | Buy |
46,016
+1,461
| +3% | +$173K | 0.47% | 59 |
|
|
2021
Q3 | $4.81M | Buy |
44,555
+2,909
| +7% | +$332K | 0.4% | 73 |
|
|
2021
Q2 | $4.69M | Buy |
41,646
+575
| +1% | +$64.8K | 0.4% | 75 |
|
|
2021
Q1 | $4.45M | Sell |
41,071
-453
| -1% | -$48.5K | 0.41% | 71 |
|
|
2020
Q4 | $4.45M | Sell |
41,524
-10,868
| -21% | -$1.04M | 0.44% | 63 |
|
|
2020
Q3 | $4.59M | Buy |
52,392
+839
| +2% | +$79K | 0.51% | 51 |
|
|
2020
Q2 | $5.06M | Sell |
51,553
-447
| -0.9% | -$39.4K | 0.61% | 42 |
|
|
2020
Q1 | $3.96M | Sell |
52,000
-2,673
| -5% | -$228K | 0.55% | 48 |
|
|
2019
Q4 | $4.84M | Sell |
54,673
-850
| -2% | -$70.6K | 0.53% | 51 |
|
|
2019
Q3 | $4.2M | Sell |
55,523
-6,177
| -10% | -$423K | 0.51% | 53 |
|
|
2019
Q2 | $4.49M | Sell |
61,700
-3,671
| -6% | -$289K | 0.55% | 52 |
|
|
2019
Q1 | $5.27M | Sell |
65,371
-666
| -1% | -$54.5K | 0.7% | 41 |
|
|
2018
Q4 | $6.09M | Sell |
66,037
-781
| -1% | -$68.7K | 0.91% | 31 |
|
|
2018
Q3 | $6.32M | Buy |
66,818
+270
| +0.4% | +$25.6K | 0.84% | 35 |
|
|
2018
Q2 | $6.17M | Buy |
66,548
+4,225
| +7% | +$413K | 0.88% | 34 |
|
|
2018
Q1 | $5.9M | Buy |
62,323
+735
| +1% | +$80.7K | 0.9% | 33 |
|
|
2017
Q4 | $5.96M | Sell |
61,588
-152
| -0.2% | -$14.3K | 0.92% | 27 |
|
|
2017
Q3 | $5.49M | Sell |
61,740
-7,590
| -11% | -$578K | 0.92% | 33 |
|
|
2017
Q2 | $5.03M | Buy |
69,330
+6,265
| +10% | +$421K | 0.84% | 38 |
|
|
2017
Q1 | $4.11M | Sell |
63,065
-29,367
| -32% | -$1.85M | 0.76% | 49 |
|
|
2016
Q4 | $5.79M | Sell |
92,432
-7,966
| -8% | -$486K | 1.17% | 28 |
|
|
2016
Q3 | $6.33M | Sell |
100,398
-289
| -0.3% | -$18.7K | 1.19% | 27 |
|
|
2016
Q2 | $6.23M | Sell |
100,687
-3,503
| -3% | -$213K | 1.27% | 28 |
|
|
2016
Q1 | $5.95M | Sell |
104,190
-9,842
| -9% | -$549K | 1.18% | 33 |
|
|
2015
Q4 | $6.75M | Buy |
114,032
+9,204
| +9% | +$530K | 1.33% | 26 |
|
|
2015
Q3 | $5.7M | Buy |
104,828
+2,116
| +2% | +$138K | 1.3% | 26 |
|
|
2015
Q2 | $6.9M | Sell |
102,712
-5,230
| -5% | -$341K | 1.55% | 22 |
|
|
2015
Q1 | $6.32M | Sell |
107,942
-1,629
| -1% | -$98.4K | 1.43% | 25 |
|
|
2014
Q4 | $7.17M | Buy |
109,571
+5,965
| +6% | +$376K | 1.64% | 20 |
|
|
2014
Q3 | $5.98M | Buy |
103,606
+2,845
| +3% | +$158K | 1.4% | 25 |
|
|
2014
Q2 | $5.69M | Buy |
100,761
+4,829
| +5% | +$253K | 1.33% | 32 |
|
|
2014
Q1 | $4.93M | Buy |
95,932
+7,014
| +8% | +$354K | 1.17% | 40 |
|
|
2013
Q4 | $4.7M | Buy |
88,918
+4,495
| +5% | +$221K | 1.13% | 40 |
|
|
2013
Q3 | $3.78M | Buy |
84,423
+4,770
| +6% | +$211K | 1.01% | 41 |
|
|
2013
Q2 | $3.29M | Buy |
+79,653
| New | +$3.48M | 0.95% | 41 |
|
Other funds holding ABBV
ECSS
ATO
Appleton Partners's ABBV Position: Q2 2026 in Review
Appleton Partners reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $186K and leaving 34,054 shares worth $8.57M. The position accounts for 0.53% of the portfolio, ranked #58.
Appleton Partners first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.9M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Appleton Partners held 34,054 shares of AbbVie worth $8.57M as of Q2 2026.
- Appleton Partners sold 866 AbbVie shares in Q2 2026, an estimated $186K.
- AbbVie made up 0.53% of Appleton Partners's portfolio in Q2 2026, its #58 holding.
- Appleton Partners first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Appleton Partners's AbbVie position peaked at $8.9M in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.